|
Q3 FY2026
As of May 31, 2026
|
Q2 FY2026
As of Feb 28, 2026
|
Q1 FY2026
As of Nov 30, 2025
|
Q4 FY2025
As of Aug 31, 2025
|
Q3 FY2025
As of May 31, 2025
|
Q2 FY2025
As of Feb 28, 2025
|
Q1 FY2025
As of Nov 30, 2024
|
Q4 FY2024
As of Aug 31, 2024
|
Q3 FY2024
As of May 31, 2024
|
Q2 FY2024
As of Feb 29, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Prepaid Expenses | ||||||||||
| Accounts Receivable | ||||||||||
| Total Other Current Assets | ||||||||||
| Total Current Assets | ||||||||||
| Total Other Assets | ||||||||||
| Intangible assets | ||||||||||
| Accumulated amortization | ||||||||||
| Total Fixed Assets | ||||||||||
| Total Intangible assets | ||||||||||
| Total Assets | ||||||||||
| STOCKHOLDERS’ DEFICIT AND LIABILITIES | ||||||||||
| Related Party Loan | ||||||||||
| Accounts Payable | ||||||||||
| Deferred Revenue | ||||||||||
| Total Current Liabilities | ||||||||||
| Director Loan | ||||||||||
| Total Long-Term Liabilities | ||||||||||
| Total Liabilities | ||||||||||
| Stockholders’ Deficit | ||||||||||
| Common stock, par value $0.001; 75,000,000 shares authorized, 3,799,469 and 5,799,469 shares issued and outstanding as of May 31, 2026 and August 31, 2025, respectively | ||||||||||
| Additional Paid-in Capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total Stockholders’ Deficit | ||||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
